UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
--------------------
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report
(Date of Earliest Event Reported): Commission File Number:
June 28, 2005 0-17449
--------------------
PROCYON CORPORATION
(Exact name of Registrant as specified in its charter)
Colorado 59-3280822
(State of incorporation) (I.R.S. Employer
Identification Number)
1300 S. Highland Ave.
Clearwater, FL 33756
(727) 447-2998
(Address of principal executive
offices and telephone number)
--------------------
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
ITEM 5.02 Departure of Directors or Principal Officers; Election of Directors;
Appointment of Principal Officers
On June 28, 2005, Procyon Corporation's (the "Company") board of directors
appointed the following persons to the following offices of the Company and its
subsidiaries:
John C. Anderson President and Chief Executive Officer
Justice W. Anderson Vice President - Sales and Marketing
James B. Anderson Chief Financial Officer
Justice W. Anderson President, Amerx Health Care Corporation
James B. Anderson President, Sirius Medical Supply, Inc.
On August 27, 2005, John C. Anderson, the Company's President and Chief
Executive Officer, died. The Company expects to begin its search for a successor
President and Chief Executive Officer in the next few weeks.
ITEM 8.01. Other Events
On August 27, 2005, Procyon Corporation's (the "Company") President and
Chief Executive Officer, died. The Company has not yet appointed a successor
President and Chief Executive Officer and expects to begin its search for a
successor in the next few weeks.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PROCYON CORPORATION
Date: September 7, 2005 By: /s/ James B. Anderson
---------------------------------
James B. Anderson,
Chief Financial Officer